RxDoctor Payments Data

Elyse Bevier-Rawls, MD

Colon & Rectal Surgery · New Orleans, LANPI 1598185118

Payments from drug & device makers

What this record shows

This record is dominated by education: $13,600 of the $17,968 with a category attached, or 75.7%. Intuitive Surgical accounts for 87.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $8,820 and has fallen 50.1% since, to $4,401 in 2025.

$17,968in general payments, 2019–2025

Across 55 payments — averaging $326.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$16K
  • Johnson & Johnson$430
  • Pentax Of America, Inc.$243
  • Baxter Healthcare$237
  • AbbVie$218
  • Kls-martin L.p.$199
  • plus $941 from 11 others

What the payments were for

  • Travel & lodging$1,3598%
  • Food & beverage$3,00917%
  • Education$13,60076%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,968 in reported general payments places this provider in the 85th percentile of 39 colon & rectal surgery providers in Louisiana.

See all colon & rectal surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$21,243
Medicare patients
51
Services billed
144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Metronidazole30$54

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in New Orleans

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →